Recent advances in radiotracers targeting novel cancer-specific biomarkers in China: a brief overview

J Zhang, F Kang, X Wang, X Chen, X Yang… - Journal of Nuclear …, 2024 - Soc Nuclear Med
Radiopharmaceuticals play a critical role in nuclear medicine, providing novel tools for
specifically delivering radioisotopes for the diagnosis and treatment of cancers. As the …

Small molecule–and peptide–drug conjugates addressing integrins: A story of targeted cancer treatment

J Paulus, N Sewald - Journal of Peptide Science, 2024 - Wiley Online Library
Targeted cancer treatment should avoid side effects and damage to healthy cells commonly
encountered during traditional chemotherapy. By combining small molecule or peptidic …

Automated Synthesis and Preclinical Evaluation of Optimized Integrin α6-Targeted Positron Emission Tomography Imaging of Pancreatic Cancer

L Chen, H Fu, H He, K Lou, Q Li, J Ye… - Molecular …, 2023 - ACS Publications
Integrin α6 has been considered a promising biomarker, is overexpressed in many tumors,
and plays a vital role in tumor formation, recurrence, and metastasis. In this study, we …

Molecular Imaging for Lung Cancer: Exploring Small Molecules, Peptides, and Beyond in Radiolabeled Diagnostics

M Ekinci, TM Magne, LMR Alencar, PBA Fechine… - Pharmaceutics, 2024 - mdpi.com
It is evident that radiolabeled drug delivery systems hold great promise in the field of lung
cancer management. The combination of therapeutic agents with radiotracers not only …

Radionuclide-based theranostics—a promising strategy for lung cancer

T Zhu, JC Hsu, J Guo, W Chen, W Cai… - European Journal of …, 2023 - Springer
Purpose This review aims to provide a comprehensive overview of the latest literature on
personalized lung cancer management using different ligands and radionuclide-based …